Fig. 3

TGFBI is associated with poor clinical outcomes of breast cancer. a Correlations of TGFBI expression with breast cancer relapse-free survival in E-MATB-365, GSE21653, and GSE25066 datasets. b Correlations of TGFBI expression with breast cancer disease-free survival in GSE4922, GSE45255, and GSE58644 datasets. c Correlations of TGFBI expression with breast cancer overall survival in GSE1456, GSE7390, GSE20685, GSE24450, GSE158309, and TCGA-BRCA datasets